Diabetes & CV Disease

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
19:06

John Tayek

2020 Updates on DM Pharmacological Management: Are Gliflozins, Glutides & Glitazones Good for Patients With CKD, Albuminuria and High CV Risk?

  • 30 views
  • January 7, 2021
06:38

Emory Diabetes Education Training Academy

In-Hospital Management of Diabetes: What Is the Efficacy of Basal Plus Correction vs. Basal Bolus in T2D?

FEATURING Guillermo Umpierrez
  • 744 views
  • January 7, 2021
  • 4
09:39

Scripps Health

Insulin Delivery Advances: What Are the Benefits of Connected Insulin Pen Systems Usage?

FEATURING David Ahn
  • 323 views
  • January 15, 2021
  • 4
19:35

Scripps Health

Pregestational Diabetes Management: Why Is Glucose Important and How to Manage Insulin Requirements? When to Do Antenatal Testing?

FEATURING Roman Starikov
  • 14 views
  • January 15, 2021
19:11

Scripps Health

Ultrasound in Diabetes: Can Left Atrial Enlargement, Carotid Plaque & Fatty Liver Increase Mortality? How to Screen for These Targets?

FEATURING Bruce Kimura
  • 14 views
  • January 15, 2021
08:54

Scripps Health

Pearls and Tips on Diabetes Self-Management Strategies

FEATURING Karla Espinosa De Los Monteros
  • 138 views
  • January 15, 2021
  • 2
05:33

Scripps Health

CV Disease & Diabetes: What Are the ADA Blood Pressure Recommendations? How to Evaluate ASCVD Risk and Statin Indication?

FEATURING Athena Philis-Tsimikas
  • 15 views
  • January 15, 2021
04:10

Scripps Health

What Are the Practical Challenges in Diabetes?

FEATURING Athena Philis-Tsimikas
  • 71 views
  • January 15, 2021
05:36

Cardiometabolic Health Congress (CMHC)

CKD & Diabetes Management: The Role of GLP-1 RAs in Kidney Protection

FEATURING Katherine R. Tuttle
  • 1,247 views
  • January 15, 2021
  • 7
05:28

Cardiometabolic Health Congress (CMHC)

SGLT-2 Inhibitors & GLP-1 RAs in CV Risk: What Are the Beneficial Effects on Reducing CVD Events?

FEATURING Robert Eckel
  • 184 views
  • January 15, 2021
09:24

Cardiometabolic Health Congress (CMHC)

SGLT-2 Inhibitors & GLP-1 RAs in CV Risk: What Have We Learned From CVOTs in T2DM? Is MACE Independent of Glucose Lowering?

FEATURING Robert Eckel
  • 271 views
  • January 15, 2021
  • 3
19:30

Cardiometabolic Health Congress (CMHC)

Lipids/BP & ASCVD Risk Reduction Guidelines: What Are the Nutrition and Lifestyle Recommendations? How to Implement SGLT2i for CV Disease in T2DM?

FEATURING Margo Minissian
  • 245 views
  • January 15, 2021
10:01

Cardiometabolic Health Congress (CMHC)

Who Is an Obesity Medicine Specialist, and Why?

FEATURING Harold Bays
  • 94 views
  • January 15, 2021
  • 1
32:10

Scripps Health

Medication Options for T2D: How Do You Determine Initial Treatment, and Which Agents Are Preferred in Patients With CVD, HF, and/or CKD?

FEATURING Lauren Vincent
  • 737 views
  • January 18, 2021
  • 5
09:50

Scripps Health

Next Generation Automatic Insulin Delivery Systems Comparison

FEATURING David Ahn, Samantha Harris
  • 98 views
  • January 18, 2021
08:43

Scripps Health

How Can Physician-Patient Relationship Affect Diabetes Medication Adherence, and What Can We Do About It?

FEATURING Tricia Santos Cavaiola
  • 267 views
  • January 18, 2021
  • 2
21:03

Cardiometabolic Health Congress (CMHC)

Trial Update on SGLT-2 Inhibitors in Heart Failure: What Is the Impact of SGLT2i on CV Outcomes, and How to Start Applying Them in Practice?

FEATURING Darren K. Mcguire
  • 492 views
  • January 18, 2021
  • 1
19:46

Cardiometabolic Health Congress (CMHC)

ASCVD Risk Reduction Recommendations: Who Benefits From High Intensity Statins? Which Non-Statin Therapies to Choose? What Is the Efficacy of Inclisiran in Patients With Elevated LDL Cholesterol?

FEATURING Margo Minissian
  • 165 views
  • January 18, 2021
  • 1
12:52

Scripps Health: 2020 Updates in Diabetes Management

Update on SGLT2i in Diabetic Kidney Disease: How Effective Are Canagliflozin & Dapagliflozin?

FEATURING Kim Harper
  • 543 views
  • January 25, 2021
  • 5
18:06

Cleveland Clinic Endocrinology & Metabolism Institute

Anti-Diabetic Medications: Do They Increase The Risk of Cancer?

FEATURING Derek LeRoith
  • 168 views
  • February 3, 2021
19:27

Cleveland Clinic Endocrinology & Metabolism Institute

Diabetes and Increased Cancer Risk: What Are the Mechanisms That Explain This Association?

FEATURING Derek LeRoith
  • 127 views
  • February 3, 2021
13:32

26th Annual San Diego Heart Failure Symposium

Hyperkalemia in Heart Failure Patients: Review of New Potassium Binders Zirconium Cyclosilicate and Patiromer

FEATURING Uri Elkayam
  • 71 views
  • February 4, 2021
39:29

37th Annual Advances in Heart Disease

Contemporary Approach for Managing PAD: What Are the Guideline Recommended Therapies? What Is the Efficacy of Statin Therapy, PCSK9 Inhibitors, Antiplatelet Agents and Anticoagulants?

FEATURING Mark Creager, Binh An Phan
  • 258 views
  • February 4, 2021
  • 2
36:06

37th Annual Advances in Heart Disease

SGLT2 Inhibitors for Heart Failure With or Without Diabetes: What Are the Results of EMPEROR-Reduced and DAPA-HF Trials? How Effective Is Quadruple Therapy?

FEATURING Jonathan Davis
  • 853 views
  • February 5, 2021
  • 7
17:35

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2 Inhibitors for Treating Patients? What Have We Learned From The PARADIGM and PARAGON Trials?

FEATURING Barry Greenberg
  • 2,016 views
  • February 5, 2021
  • 22

Diabetes & CV Disease

All Topics: